Skip to main content

Want a detailed portfolio tracker?

Stablecoin Development (NBY) P/E

Stablecoin Development (NBY) P/E history. The TTM Stablecoin Development (NBY) P/E is 0.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Stablecoin Development (NBY)

YearP/EChange
20260.00N/A

Comparison Stablecoin Development (NBY) P/E with competitors

Stablecoin Development (NBY) P/E is 0.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-60.95%
ENLVEnlivex Ltd0.07+1618.40%
FGENFibroGen Inc0.24+5414.35%
CHRSCoherus Biosciences Inc0.85+19392.85%
FBIOFortress Biotech Inc0.95+21701.67%
ORMPOramed Pharmaceuticals Inc1.50+34428.88%
AGENAgenus Inc3.01+69038.16%
INVAInnoviva Inc3.15+72355.51%
VXRTVaxart Inc3.55+81446.04%
CRMDCorMedix Inc3.63+83254.04%
CVACCureVac N.V.4.45+102027.83%
GLPGGalapagos NV4.86+111520.39%
SRPTSarepta Therapeutics Inc4.88+112053.38%
ABEOAbeona Therapeutics Inc5.39+123664.08%
ABUSArbutus Biopharma Corp5.60+128444.83%
ZVRAZevra Therapeutics Inc5.89+135143.84%
SPROSpero Therapeutics Inc6.23+142982.34%
CGENCompugen Ltd6.31+144946.55%
RIGLRigel Pharmaceuticals6.87+157767.95%
SLXNSilexion Therapeutics Corp7.30+167508.64%
OMEROmeros Corporation9.26+212596.04%
AUPHAurinia Pharmaceuticals Inc9.58+220089.93%
PLXProtalix BioTherapeutics Inc10.89+250093.07%
ACADAcadia Pharmaceuticals Inc11.73+269333.21%
TBPHTheravance Biopharma Inc12.26+281591.77%
ADMAAdma Biologics Inc12.42+285175.60%
HRMYHarmony Biosciences Holdings Inc13.82+317384.18%
SABSSAB Biotherapeutics Inc14.14+324643.74%
NAGENiagen Bioscience Inc14.82+340309.24%
INCYIncyte Corp15.82+363383.62%
REGNRegeneron Pharmaceuticals Inc15.86+364167.01%
PBYIPuma Biotechnology Inc17.32+397685.07%
CPRXCatalyst Pharmaceuticals Inc17.44+400524.57%
EXELExelixis Inc17.54+402792.03%
TGTXTG Therapeutics Inc18.97+435597.91%
MDXGMimedx Group Inc20.55+472042.76%
XOMAXOMA Royalty Corp22.87+525402.86%
ARGXArgen X SE24.30+558100.76%
CTMXCytomX Therapeutics Inc24.82+570118.10%
XOMAOXOMA Royalty Corp25.34+582149.21%
HALOHalozyme Therapeutics Inc25.62+588556.47%
XOMAPXOMA Royalty Corp25.67+589622.43%
VRTXVertex Pharmaceuticals Inc27.99+643026.17%
RPRXRoyalty Pharma plc - Class A28.69+658942.08%
SLNOSoleno Therapeutics Inc29.02+666472.73%
ASNDAscendis Pharma A/S30.09+691058.76%
LGNDLigand Pharmaceuticals Inc - Class B37.91+870857.03%
APLSApellis Pharmaceuticals Inc39.02+896339.02%
BMRNBiomarin Pharmaceutical Inc42.21+969637.65%
KRYSKrystal Biotech Inc45.34+1041580.85%
ONCBeiGene Ltd69.54+1597461.30%
PHARPharming Group N.V.75.03+1723472.17%
TECHBio-Techne Corp101.96+2342203.00%
VCELVericel Corp109.92+2525137.12%
ALNYAlnylam Pharmaceuticals Inc117.96+2709927.49%
GMABGenmab140.29+3222818.00%
TLXTelix Pharmaceuticals Ltd162.15+3725058.09%
CORTCorcept Therapeutics Inc212.86+4889903.42%